Results 241 to 250 of about 269,242 (268)

Alemtuzumab in Stem Cell Transplantation

Medical Oncology, 2002
Alemtuzumab, otherwise called CAMPATH-1H, is a humanized monoclonal antibody directed against the CD52 antigen of lymphocytes. It is one of a family of CAMPATH-1 antibodies that have been used over the last 20 yr in stem cell transplantation for depletion of donor and recipient T-cells to prevent graft-versus-host disease and graft rejection.
openaire   +2 more sources

Hematopoietic stem cell transplantation

Current Opinion in Hematology, 2004
Nonniekaye Shelburne, Margaret Bevans, William P. Hogle   +2 more
openaire   +4 more sources

Human Stem Cell Transplantation

Leukemia & Lymphoma, 1993
openaire   +2 more sources

Stem cell transplantation for immunodeficiency

Springer Seminars in Immunopathology, 1998
A, Fischer, E, Haddad, N, Jabado, J L, Casanova, S, Blanche, F, Le Deist, M, Cavazzana-Calvo   +6 more
openaire   +2 more sources

The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer

Ca-A Cancer Journal for Clinicians, 1996
Frederick R Appelbaum
exaly  

Immunotoxins till the soil for stem cell transplantation

Nature Reviews Drug Discovery, 2016
Megan Cully, Cully Megan
exaly  

Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

New England Journal of Medicine, 2012
Michel Attal, Valerie Lauwers-Cancès, Philippe Moreau   +2 more
exaly  

Hematopoietic Stem Cell Transplantation<subtitle>A Global Perspective</subtitle>

JAMA - Journal of the American Medical Association, 2010
Alois Gratwohl, Helen Baldomero, Mahmoud Aljurf   +2 more
exaly  

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

New England Journal of Medicine, 2012
Craig C Hofmeister, Paul G Richardson, Sérgio Giralt   +2 more
exaly  

Stem Cells/Stem Cell Transplantation

2008
openaire   +1 more source